Your browser doesn't support javascript.
Montrer: 20 | 50 | 100
Résultats 1 - 11 de 11
Filtre
1.
J Bras Nefrol ; 42(2 suppl 1): 44-46, 2020 Aug 26.
Article Dans Anglais, Portugais | MEDLINE | ID: covidwho-2293806

Résumé

INTRODUCTION: Palliative care is an approach aimed at relieving suffering, controlling symptoms and seeking to improve quality of life. It must be offered in conjunction with standard treatment for any disease that threatens the continuation of life, such as a Covid-19 infection. DISCUSSION: The bioethical principles and strategies used by palliative medicine can assist nephrologists in the care of patients with renal dysfunction, who face the difficulties of isolation at the beginning and follow-up of dialysis in outpatient treatment, and those who are at risk for a more serious disease progress. Some of them: - a Shared decision making, which enables the patient and family to participate as facilitators in the systematization of the team's reasoning, in addition to respecting the principle of autonomy; - Symptom Management: which should be a priority to ensure relief of suffering even in times of social isolation; - Communication skills: making it possible to alleviate suffering in announcing bad news or complex decisions through communication techniques;; - Bereavement assistance: which in acute situations such as the pandemic, causing unexpected losses, the importance of sympathy from healthcare professionals becomes even greater. CONCLUSION: The principles of palliative care are essential to face the challenges of a planet-wide crisis, which raises human suffering in all dimensions, and which requires the construction of strategies that can keep patients assisted, comfortable and with measures proportional to their clinical condition and preferences.


Sujets)
Betacoronavirus , Infections à coronavirus/épidémiologie , Soins palliatifs/méthodes , Pneumopathie virale/épidémiologie , Traitement substitutif de l'insuffisance rénale/normes , Deuil (perte) , COVID-19 , Communication , Prise de décision partagée , Humains , Néphrologie/normes , Pandémies , Traitement substitutif de l'insuffisance rénale/méthodes , SARS-CoV-2 , Évaluation des symptômes/méthodes
2.
J Bras Nefrol ; 42(2 suppl 1): 12-14, 2020 Aug 26.
Article Dans Anglais, Portugais | MEDLINE | ID: covidwho-2291145

Résumé

Patients with Chronic Kidney Disease are among those individuals at increased risk for developing more serious forms of Covid-19. This increased risk starts in the pre-dialysis phase of the disease. Providing useful information for these patients, in language that facilitates the understanding of the disease, can help nephrologists and other healthcare professionals to establish a more effective communication with these patients and help minimize contagion and the risks of serious illness in this population.


Sujets)
Betacoronavirus , Infections à coronavirus/prévention et contrôle , Pandémies/prévention et contrôle , Éducation du patient comme sujet/normes , Pneumopathie virale/prévention et contrôle , Insuffisance rénale chronique/complications , Activités de la vie quotidienne , COVID-19 , Infections à coronavirus/diagnostic , Infections à coronavirus/épidémiologie , Interventions chirurgicales non urgentes , Hygiène des mains/méthodes , Hygiène des mains/normes , Établissements de santé , Personnel de santé , Humains , Néphrologie/normes , Espace personnel , Pneumopathie virale/diagnostic , Pneumopathie virale/épidémiologie , Dialyse rénale , Facteurs de risque , SARS-CoV-2 , Évaluation des symptômes
3.
J Bras Nefrol ; 42(2 suppl 1): 4-8, 2020 Aug 26.
Article Dans Anglais, Portugais | MEDLINE | ID: covidwho-845305

Résumé

The Covid-19 pandemic brought several challenges to the healthcare system: diagnosis, treatment and measures to prevent the spread of the disease. With the greater availability and variety of diagnostic tests, it is essential to properly interpret them. This paper intends to help dialysis units concerning the use of clinical criteria and diagnostic tests for decision making regarding the discontinuation of isolation of patients with suspected or confirmed Covid-19, as well as the return to work activities for employees with suspected or confirmed Covid-19.


Sujets)
Betacoronavirus , Techniques de laboratoire clinique/normes , Infections à coronavirus/diagnostic , Néphrologie/normes , Pneumopathie virale/diagnostic , Dialyse rénale , Reprise du travail , Algorithmes , Brésil , COVID-19 , Dépistage de la COVID-19 , Liste de contrôle , Prise de décision clinique , Techniques de laboratoire clinique/méthodes , Infections à coronavirus/épidémiologie , Humains , Maladies professionnelles/diagnostic , Pandémies , Isolement du patient , Pneumopathie virale/épidémiologie , Réaction de polymérisation en chaine en temps réel/méthodes , Réaction de polymérisation en chaine en temps réel/normes , SARS-CoV-2 , Sociétés médicales/normes , Service hospitalier d'urologie/normes
4.
Am J Kidney Dis ; 77(1): 142-148, 2021 01.
Article Dans Anglais | MEDLINE | ID: covidwho-799495

Résumé

The coronavirus disease 2019 (COVID-19) pandemic, technological advancements, regulatory waivers, and user acceptance have converged to boost telehealth activities. Due to the state of emergency, regulatory waivers in the United States have made it possible for providers to deliver and bill for services across state lines for new and established patients through Health Insurance Portability and Accountability Act (HIPAA)- and non-HIPAA-compliant platforms with home as the originating site and without geographic restrictions. Platforms have been developed or purchased to perform videoconferencing, and interdisciplinary dialysis teams have adapted to perform virtual visits. Telehealth experiences and challenges encountered by dialysis providers, clinicians, nurses, and patients have exposed health care disparities in areas such as access to care, bandwidth connectivity, availability of devices to perform telehealth, and socioeconomic and language barriers. Future directions in telehealth use, quality measures, and research in telehealth use need to be explored. Telehealth during the public health emergency has changed the practice of health care, with the post-COVID-19 world unlikely to resemble the prior era. The future impact of telehealth in patient care in the United States remains to be seen, especially in the context of the Advancing American Kidney Health Initiative.


Sujets)
Comités consultatifs/normes , Hémodialyse à domicile/normes , Défaillance rénale chronique/épidémiologie , Néphrologie/normes , Sociétés médicales/normes , Télémédecine/normes , Comités consultatifs/tendances , Hémodialyse à domicile/tendances , Humains , Défaillance rénale chronique/thérapie , Néphrologie/tendances , Sociétés médicales/tendances , Télémédecine/tendances , États-Unis/épidémiologie
5.
J Bras Nefrol ; 42(2 suppl 1): 41-43, 2020 Aug 26.
Article Dans Anglais, Portugais | MEDLINE | ID: covidwho-740465

Résumé

Vascular accesses for hemodialysis are considered the patient's lifeline and their maintenance is essential for treatment continuity. Following the example of institutions in other countries affected by the Covid-19 pandemic, the Brazilian Society of Nephrology developed these guidelines for healthcare services, elaborating on the importance of carrying out procedures for the preparation and preservation of vascular accesses. Creating definitive accesses for hemodialysis, grafts and arteriovenous fistulas are non-elective procedures, as well as the transition from the use of non-tunneled catheters to tunneled catheters, which cause less morbidity. In the case of patients with suspected or confirmed coronavirus infection, one may postpone the procedures for the quarantine period, to avoid spreading the disease.


Sujets)
Anastomose chirurgicale artérioveineuse/méthodes , Betacoronavirus , Infections à coronavirus/épidémiologie , Pneumopathie virale/épidémiologie , Dialyse rénale/méthodes , Dispositifs d'accès vasculaires , Comités consultatifs , Anastomose chirurgicale artérioveineuse/normes , Brésil , COVID-19 , Interventions chirurgicales non urgentes/méthodes , Interventions chirurgicales non urgentes/normes , Urgences , Humains , Néphrologie/normes , Pandémies , SARS-CoV-2 , Sociétés médicales
6.
J Bras Nefrol ; 42(2 suppl 1): 32-35, 2020 Aug 26.
Article Dans Anglais, Portugais | MEDLINE | ID: covidwho-740463

Résumé

INTRODUCTION: The impact of the new coronavirus (SARS-COV-2) and its worldwide clinical manifestations (COVID-19) imposed specific regional recommendations for populations in need of specialized care, such as children and adolescents with kidney diseases, particularly in renal replacement therapies (RRT). We present the recommendations of the Brazilian Society of Nephrology regarding the treatment of pediatric patients with kidney diseases during the COVID-19 pandemic. METHODS: Articles and documents from medical societies and government agencies on specific recommendations for children on RRT in relation to COVID-19 as well as those focused on epidemiological aspects of this condition in Brazil Were evaluated and analyzed. RESULTS: We present recommendations on outpatient care, transportation to dialysis centers, peritoneal dialysis, hemodialysis, and kidney transplantation in children and adolescents during the COVID-19 pandemic in Brazil. DISCUSSION: Despite initial observations of higher mortality rates in specific age groups (the elderly) and with comorbidities (obese, diabetics, and those with cardiovascular diseases), patients with chronic kidney disease (CKD) on RRT are particularly prone to develop COVID-19. Specific measures must be taken to reduce the risk of contracting SARS-CoV-2 and developing COVID-19, especially during transport to dialysis facilities, as well as on arrival and in contact with other patients.


Sujets)
Betacoronavirus , Infections à coronavirus/épidémiologie , Maladies du rein/thérapie , Pneumopathie virale/épidémiologie , Traitement substitutif de l'insuffisance rénale/normes , Adolescent , Soins ambulatoires , Brésil/épidémiologie , COVID-19 , Enfant , Infections à coronavirus/diagnostic , Infections à coronavirus/prévention et contrôle , Infections à coronavirus/transmission , Humains , Hygiène/normes , Transplantation rénale , Masques , Néphrologie/normes , Maladies professionnelles/prévention et contrôle , Pandémies/prévention et contrôle , Isolement du patient , Pédiatrie , Pneumopathie virale/diagnostic , Pneumopathie virale/prévention et contrôle , Pneumopathie virale/transmission , Traitement substitutif de l'insuffisance rénale/méthodes , SARS-CoV-2 , Sociétés médicales , Évaluation des symptômes , Transport sanitaire
7.
J Bras Nefrol ; 42(2 suppl 1): 22-31, 2020 08 26.
Article Dans Anglais, Portugais | MEDLINE | ID: covidwho-740462

Résumé

We produced this document to bring pertinent information to the practice of nephrology, as regards to the renal involvement with COVID-19, the management of acute kidney injury cases, and practical guidance on the provision of dialysis support.As information on COVID-19 evolves at a pace never before seen in medical science, these recommendations, although based on recent scientific evidence, refer to the present moment. The guidelines may be updated when published data and other relevant information become available.


Sujets)
Atteinte rénale aigüe/thérapie , Betacoronavirus , Infections à coronavirus/épidémiologie , Pneumopathie virale/épidémiologie , Traitement substitutif de l'insuffisance rénale/normes , Dispositifs d'accès vasculaires/normes , Atteinte rénale aigüe/épidémiologie , Atteinte rénale aigüe/étiologie , Brésil/épidémiologie , COVID-19 , Prise de décision clinique , Infections à coronavirus/traitement médicamenteux , Infections à coronavirus/prévention et contrôle , Soins de réanimation , Humains , Rein/effets des médicaments et des substances chimiques , Néphrologie/normes , Maladies professionnelles/prévention et contrôle , Pandémies/prévention et contrôle , Équipement de protection individuelle , Pneumopathie virale/traitement médicamenteux , Pneumopathie virale/prévention et contrôle , Récupération fonctionnelle , Traitement substitutif de l'insuffisance rénale/méthodes , Ventilation artificielle/effets indésirables , SARS-CoV-2 , Sociétés médicales
8.
J Bras Nefrol ; 42(2 suppl 1): 18-21, 2020 Aug 26.
Article Dans Anglais, Portugais | MEDLINE | ID: covidwho-740461

Résumé

Considering the new coronavirus epidemic (Covid-19), the Brazilian Society of Nephrology, represented by the Peritoneal Steering Committee, in agreement with the and the Dialysis Department, developed a series of recommendations for good clinical practices for peritoneal dialysis (PD) clinics, to be considered during the period of the Covid-19 epidemic. We aim to minimize the disease spread, protecting patients and staff, and ensuring the quality of the treatment provided and adequate follow-up for PD patients. The recommendations suggested at this moment must be adapted to each clinic's reality and the conditions of the structural and human resources, dependent on the adequate financial provision of the public health system for its full implementation.


Sujets)
Betacoronavirus , Infections à coronavirus/prévention et contrôle , Défaillance rénale chronique/thérapie , Pandémies/prévention et contrôle , Dialyse péritonéale/normes , Pneumopathie virale/prévention et contrôle , Brésil , COVID-19 , Infections à coronavirus/diagnostic , Infections à coronavirus/épidémiologie , Désinfection/méthodes , Désinfection/normes , Humains , Défaillance rénale chronique/complications , Masques , Néphrologie/normes , Maladies professionnelles/prévention et contrôle , Équipe soignante , Éducation du patient comme sujet , Isolement du patient/méthodes , Isolement du patient/normes , Dialyse péritonéale/instrumentation , Dialyse péritonéale/méthodes , Équipement de protection individuelle , Pneumopathie virale/diagnostic , Pneumopathie virale/épidémiologie , SARS-CoV-2 , Sociétés médicales , Télémédecine/législation et jurisprudence , Télémédecine/méthodes , Télémédecine/normes , Service hospitalier d'urologie/organisation et administration , Service hospitalier d'urologie/normes
9.
J Bras Nefrol ; 42(2 suppl 1): 15-17, 2020 Aug 26.
Article Dans Anglais, Portugais | MEDLINE | ID: covidwho-740460

Résumé

Dialysis units are environments potentially prone to the spread of Covid-19. Patients cannot suspend treatment, and they often have comorbidities, which assigns them a higher risk and worse prognosis. The Brazilian Society of Nephrology prepared this document of good practices, whose technical recommendations deal with general measures that can be implemented to reduce the risk of transmission and prevent the spread of the disease in the unit.


Sujets)
Betacoronavirus , Infections à coronavirus/prévention et contrôle , Pandémies/prévention et contrôle , Pneumopathie virale/prévention et contrôle , Dialyse rénale/normes , Service hospitalier d'urologie/normes , Brésil , COVID-19 , Infections à coronavirus/diagnostic , Infections à coronavirus/épidémiologie , Infections à coronavirus/transmission , Désinfection/méthodes , Désinfection/normes , Humains , Masques , Néphrologie/normes , Isolement du patient/méthodes , Isolement du patient/normes , Équipement de protection individuelle , Pneumopathie virale/diagnostic , Pneumopathie virale/épidémiologie , Pneumopathie virale/transmission , Insuffisance rénale chronique , SARS-CoV-2 , Sociétés médicales/normes , Évaluation des symptômes
10.
J Bras Nefrol ; 42(2 suppl 1): 9-11, 2020 Aug 26.
Article Dans Anglais, Portugais | MEDLINE | ID: covidwho-740458

Résumé

These recommendations were created after the publication of informative note 3/2020- CGGAP/DESF/SAPS/MS, of April 4, 2020, in which the Brazilian Ministry of Health recommended the use of a cloth mask by the population, in public places. Taking into account the necessary prioritization of the provision of Personal Protective Equipment (PPE) for patients with suspected or confirmed disease, as well as for healthcare professionals, the SBN is favorable concerning the wear of cloth masks by chronic kidney patients in dialysis, in public settings, except in the dialysis setting. The present recommendations have eleven items, related to this rationale, the procedures, indications, contraindications, as well as appropriate fabrics for the mask, and hygiene care to be adopted. These recommendations may change, at any time, in the light of new evidence.


Sujets)
Betacoronavirus , Infections à coronavirus/prévention et contrôle , Masques/normes , Pandémies/prévention et contrôle , Équipement de protection individuelle/normes , Pneumopathie virale/prévention et contrôle , Dialyse rénale , Textiles , Brésil , COVID-19 , Infections à coronavirus/épidémiologie , Personnel de santé , Humains , Néphrologie/normes , Maladies professionnelles/prévention et contrôle , Pneumopathie virale/épidémiologie , Vêtements de protection/normes , Insuffisance rénale chronique/thérapie , SARS-CoV-2 , Sociétés médicales , Service hospitalier d'urologie/normes
11.
Nephrol Dial Transplant ; 35(6): 920-925, 2020 06 01.
Article Dans Anglais | MEDLINE | ID: covidwho-343463

Résumé

The coronavirus disease 2019 (COVID-19) pandemic has created major challenges for all countries around the globe. Retrospective studies have identified hypertension, cardiovascular disease, diabetes and older age as risk factors for high morbidity and mortality from COVID-19. There is a general concern that patients with immune-mediated kidney diseases, namely those on immunosuppressive therapies and/or those with more advanced kidney failure, could particularly be at risk for adverse outcomes due to a compromised antiviral immunity. Uncertainties exist on how management routines should be reorganized to minimize the risk of severe acute respiratory syndrome coronavirus 2 infection and what measures are necessary for infected patients. The aim of the present review of the Immunonephrology Working Group of the European Renal Association-European Dialysis and Transplant Association is to provide recommendations for the management of patients with immune-mediated kidney diseases based on the available evidence, similar circumstances with other infectious organisms and expert opinions from across Europe. Such recommendations may help to minimize the risk of encountering COVID-19 or developing complications during COVID-19 in patients with immune-mediated kidney disease.


Sujets)
Infections à coronavirus/immunologie , Infections à coronavirus/thérapie , Maladies du rein/immunologie , Maladies du rein/thérapie , Néphrologie/normes , Pneumopathie virale/immunologie , Pneumopathie virale/thérapie , Antiviraux , Betacoronavirus , COVID-19 , Infections à coronavirus/complications , Europe , Humains , Immunosuppresseurs/usage thérapeutique , Maladies du rein/complications , Pandémies , Pneumopathie virale/complications , Dialyse rénale , Études rétrospectives , Appréciation des risques , Facteurs de risque , SARS-CoV-2 , Sociétés médicales
SÉLECTION CITATIONS
Détails de la recherche